Skip Navigation
.: HRSA | 340B Program :.
Login | Help  
Useful Links
Covered Entities
» Search Covered Entities

» Download Medicaid Exclusion File

» Download Orphan Drug Selection File

» Submit a Change/Termination Request

Contract Pharmacies
» Search Contract Pharmacies

» Request Contract Terminations

» View Contract Pharmacy Carve-Ins

» Search Manufacturers

What's New


HRSA understands that the 340B Drug Pricing Program audit process can be challenging and confusing. In order to clarify the audit process and to relay upcoming changes for FY15, we recently held an informational webinar for program stakeholders.

Questions on 340B program requirements can be directed to ApexusAnswers, a service of the 340B prime vendor program, at 888-340-2787 or by e-mail to

Important Notifications


The 340B database upgrade has been postponed to approximately 2-3pm EST on 12/19/2014 (the exact date and time remain subject to change; HRSA will continue to update this notice as needed). The new version of the registration application features interface enhancements to improve performance, navigation and general ease-of-use, as well as the ability to request ALL authorizing official changes online -- paper forms will no longer be required or accepted for authorizing official changes where the existing official is unavailable to certify the request.


HRSA has completed review of all registrations received for a program start date of January 1, 2015. Authorizing officials listed on registrations that were unable to be approved should have been informed via e-mail with instructions for re-registration (if appropriate); covered entities that have not received notice of approval or rejection should contact ApexusAnswers via e-mail, phone or online chat for additional information or with any other questions or concerns.

The next registration period will be January 1-15, 2015, for a program start date of April 1, 2015. HRSA strongly encourages hospitals to review the supplemental registration guidance applicable to their entity types; additional information for all entities is available on the main Office of Pharmacy Affairs website.

You are entering an official US Government computer network! NEVER save your user-ID or password when accessing this system (especially on non-government computers). Please Note: You are entering an official United States government system, which may be used only for authorized purposes. This system may contain nonpublic HRSA information within the meaning of 12 CFR 4.32(b) that is subject to use and disclosure restrictions specified at 12 CFR 4.37. The unauthorized use or disclosure of nonpublic HRSA information or the unauthorized modification of any information stored on this system may result in criminal prosecution or administrative proceedings.

Public Burden Statement: An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The OMB control number for this project is 0915-0327. Public reporting burden for this collection of information is estimated to average one to two hours per response for registration and thirty minutes for recertification, including the time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-29, Rockville, Maryland, 20857.

OMB Number: 0915-0327, Expiration: 10/31/2015
U.S. Department of Health and Human Services (HHS)
Health Resources and Services Administration (HRSA)
Office of Pharmacy Affairs (OPA) - 340B Program
December 18, 2014
3:54 PM ET
Questions, Comments, or Suggestions
Email Us:
Call Us: 1 - 888 - 340 - 2787

Viewers & Players